Ingrid Øra
21 – 30 of 104
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum
- Contribution to journal › Article
-
Mark
The pediatric precision oncology INFORM registry : clinical outcome and benefit for patients with very high-evidence targets
- Contribution to journal › Article
-
Mark
NTRK Alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets
- Contribution to journal › Letter
-
Mark
Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib
- Contribution to journal › Article
-
Mark
Prevalence of germline pathogenic variants in 22 cancer susceptibility genes in Swedish pediatric cancer patients
- Contribution to journal › Article
-
Mark
Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)
- Contribution to journal › Article
-
Mark
Cognitive Fatigue and Processing Speed in Children Treated for Brain Tumours
- Contribution to journal › Article
-
Mark
Characterization of Cardiac, Vascular, and Metabolic Changes in Young Childhood Cancer Survivors
- Contribution to journal › Article
- 2020
-
Mark
Auditory hypersensitivity and attention in survivors of paediatric brain tumours
(2020) the International Neuropsychological Society 2020 Virtual Event
- Contribution to conference › Poster
-
Mark
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe : A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
- Contribution to journal › Article
